Protein Name |
Pfam ID |
Percentage of Identity (%) |
E value |
Mixed lineage kinase 1 (MAP3K9)
|
|
31.900 (89/279) |
1.48E-27 |
Serine/threonine-protein kinase 26 (STK26)
|
|
29.528 (75/254) |
1.39E-22 |
Serine/threonine-protein kinase Nek4 (NEK4)
|
|
29.134 (74/254) |
2.78E-21 |
Serine/threonine-protein kinase 33 (STK33)
|
|
29.333 (66/225) |
4.26E-21 |
Serine/threonine-protein kinase Nek5 (NEK5)
|
|
26.087 (66/253) |
6.29E-21 |
MST-1 protein kinase (STK4)
|
|
32.178 (65/202) |
1.02E-20 |
Receptor-interacting serine/threonine-protein kinase 3 (RIPK3)
|
|
29.433 (83/282) |
4.60E-20 |
Fused homolog (STK36)
|
|
28.638 (61/213) |
4.73E-20 |
Serine/threonine-protein kinase 3 (STK3)
|
|
31.683 (64/202) |
5.07E-20 |
Serine/threonine-protein kinase 24 (STK24)
|
|
28.235 (72/255) |
6.79E-20 |
Serine/threonine-protein kinase MARK1 (MARK1)
|
|
28.409 (75/264) |
1.52E-19 |
Microtubule affinity regulating kinase 3 (MARK3)
|
|
28.030 (74/264) |
1.78E-19 |
NIMA-related kinase 7 (NEK7)
|
|
25.000 (67/268) |
2.18E-19 |
Serine/threonine-protein kinase PAK 5 (PAK5)
|
|
31.336 (68/217) |
4.79E-19 |
Serine/threonine-protein kinase MARK2 (MARK2)
|
|
28.455 (70/246) |
9.01E-19 |
Ribosomal protein S6 kinase alpha-1 (RSK1)
|
|
27.132 (70/258) |
1.05E-18 |
Polo-like kinase 4 (PLK4)
|
|
26.190 (77/294) |
1.33E-18 |
Calcium/calmodulin-dependent protein kinase type 1 (CAMK1)
|
|
27.434 (62/226) |
1.38E-18 |
Serine/threonine-protein kinase PAK 6 (PAK6)
|
|
30.374 (65/214) |
1.65E-18 |
Serine/threonine-protein kinase ULK2 (ULK2)
|
|
29.954 (65/217) |
2.96E-18 |
Ribosomal protein S6 kinase alpha-6 (RSK6)
|
|
26.772 (68/254) |
3.22E-18 |
Serine/threonine-protein kinase Nek11 (NEK11)
|
|
24.735 (70/283) |
3.39E-18 |
MAP/microtubule affinity-regulating kinase 4 (MARK4)
|
|
29.070 (75/258) |
3.49E-18 |
Omphalocele kinase 1 (NUAK1)
|
|
25.600 (64/250) |
5.40E-18 |
Ribosomal protein S6 kinase alpha-2 (RSK2)
|
|
25.957 (61/235) |
6.25E-18 |
Serine/threonine-protein kinase Nek8 (NEK8)
|
|
26.772 (68/254) |
9.58E-18 |
Ribosomal protein S6 kinase alpha-3 (RSK3)
|
|
28.516 (73/256) |
1.44E-17 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 (PRKAA1)
|
|
28.767 (63/219) |
1.53E-17 |
Myosin light chain kinase 2 (MYLK2)
|
|
26.027 (57/219) |
6.00E-17 |
NIMA-related kinase 6 (NEK6)
|
|
22.603 (66/292) |
8.03E-17 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 (PRKAA2)
|
|
24.545 (81/330) |
9.16E-17 |
Serine/threonine-protein kinase ICK (CILK1)
|
|
28.448 (66/232) |
1.04E-16 |
Inhibitor of nuclear factor kappa-B kinase alpha (IKKA)
|
|
27.619 (58/210) |
1.52E-16 |
Serine/threonine-protein kinase 25 (STK25)
|
|
28.638 (61/213) |
2.13E-16 |
STE20-related serine/threonine-protein kinase (SLK)
|
|
28.629 (71/248) |
3.92E-16 |
Ribosomal protein S6 kinase beta-1 (S6K1)
|
|
24.719 (66/267) |
4.20E-16 |
Serine/threonine-protein kinase ULK1 (ULK1)
|
|
29.358 (64/218) |
4.43E-16 |
Calcium/calmodulin-dependent protein kinase type 1G (CAMK1G)
|
|
26.126 (58/222) |
4.59E-16 |
PAK-4 protein kinase (PAK4)
|
|
29.954 (65/217) |
4.83E-16 |
Serine/threonine-protein kinase PLK3 (PLK3)
|
|
26.087 (78/299) |
6.47E-16 |
Serine/threonine-protein kinase NIM1 (NIM1K)
|
|
28.000 (70/250) |
7.98E-16 |
Serine/threonine-protein kinase H1 (PSKH1)
|
|
27.099 (71/262) |
8.45E-16 |
Protein kinase D (PRKD1)
|
|
28.293 (58/205) |
9.88E-16 |
Serine/threonine-protein kinase D2 (PRKD2)
|
|
28.293 (58/205) |
9.98E-16 |
NUAK family SNF1-like kinase 2 (NUAK2)
|
|
26.295 (66/251) |
1.04E-15 |
Serine/threonine-protein kinase Nek9 (NEK9)
|
|
25.194 (65/258) |
1.10E-15 |
PKC-delta-interacting protein kinase (RIPK4)
|
|
28.467 (78/274) |
1.11E-15 |
Myosin light chain kinase family member 4 (MYLK4)
|
|
27.315 (59/216) |
1.45E-15 |
Aurora kinase C (AURKC)
|
|
24.621 (65/264) |
2.12E-15 |
NIMA-related kinase 2 (NEK2)
|
|
24.809 (65/262) |
2.40E-15 |
Salt-inducible kinase 2 (SIK2)
|
|
28.632 (67/234) |
2.66E-15 |
Serine/threonine-protein kinase 10 (STK10)
|
|
27.273 (60/220) |
2.68E-15 |
Cyclin-dependent kinase 7 (CDK7)
|
|
27.273 (54/198) |
2.76E-15 |
ERK activator kinase 5 (MAP2K5)
|
|
24.723 (67/271) |
3.26E-15 |
Extracellular signal-regulated kinase 2 (ERK2)
|
|
28.986 (60/207) |
3.77E-15 |
NIMA-related kinase 1 (NEK1)
|
|
22.394 (58/259) |
4.12E-15 |
Putative 3-phosphoinositide-dependent protein kinase 2 (PDPK2P)
|
|
25.121 (52/207) |
4.23E-15 |
Extracellular signal-regulated kinase 5 (ERK5)
|
|
29.048 (61/210) |
4.78E-15 |
Phosphoinositide dependent protein kinase-1 (PDPK1)
|
|
25.121 (52/207) |
4.81E-15 |
SIK family kinase 3 (SIK3)
|
|
26.740 (73/273) |
6.14E-15 |
Ribosomal protein S6 kinase alpha-5 (RSK5)
|
|
25.108 (58/231) |
7.12E-15 |
Serine/threonine-protein kinase Nek3 (NEK3)
|
|
22.519 (59/262) |
7.48E-15 |
Salt-inducible kinase 1 (SIK1)
|
|
27.715 (74/267) |
8.53E-15 |
Putative serine/threonine-protein kinase SIK1B (SIK1B)
|
|
27.715 (74/267) |
9.13E-15 |
Inhibitor of nuclear factor kappa-B kinase beta (IKKB)
|
|
26.540 (56/211) |
1.08E-14 |
Serine/threonine-protein kinase MAK (MAK)
|
|
26.840 (62/231) |
1.16E-14 |
Serine/threonine-protein kinase D3 (PRKD3)
|
|
27.404 (57/208) |
1.17E-14 |
Apoptosis signal-regulating kinase 1 (MAP3K5)
|
|
29.808 (62/208) |
1.21E-14 |
Death-associated protein kinase 1 (DAPK1)
|
|
26.484 (58/219) |
1.60E-14 |
Calcium/calmodulin-dependent protein kinase type 1D (CAMK1D)
|
|
25.541 (59/231) |
1.69E-14 |
Serine/threonine-protein kinase Sgk3 (SGK3)
|
|
29.464 (66/224) |
2.03E-14 |
Death-associated protein kinase 3 (DAPK3)
|
|
26.027 (57/219) |
2.28E-14 |
Cyclin-dependent kinase 2 (CDK2)
|
|
28.358 (57/201) |
2.47E-14 |
Ste-20-related kinase (STK39)
|
|
24.823 (70/282) |
2.79E-14 |
MAP kinase p38 (MAPK12)
|
|
30.088 (68/226) |
3.96E-14 |
Polo-like kinase 2 (PLK2)
|
|
24.603 (62/252) |
4.05E-14 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha (CAMK2A)
|
|
25.221 (57/226) |
4.13E-14 |
Extracellular signal-regulated kinase 1 (ERK1)
|
|
29.353 (59/201) |
4.16E-14 |
Protein kinase C delta (PRKCD)
|
|
24.889 (56/225) |
4.25E-14 |
Calcium/calmodulin-dependent protein kinase type 1B (PNCK)
|
|
25.738 (61/237) |
5.97E-14 |
Mitogen-activated protein kinase 15 (MAPK15)
|
|
28.922 (59/204) |
6.08E-14 |
Putative serine/threonine-protein kinase PRKY (PRKY)
|
|
26.168 (56/214) |
7.13E-14 |
Checkpoint kinase-1 (CHK1)
|
|
30.332 (64/211) |
7.31E-14 |
Serine/threonine-protein kinase tousled-like 2 (TLK2)
|
|
26.009 (58/223) |
9.67E-14 |
Serine/threonine-protein kinase 32A (STK32A)
|
|
27.232 (61/224) |
9.85E-14 |
Apoptosis signal-regulating kinase 2 (MAP3K6)
|
|
28.326 (66/233) |
1.01E-13 |
Aurora kinase A (AURKA)
|
|
26.906 (60/223) |
1.12E-13 |
Oxidative stress responsive 1 (OXSR1)
|
|
26.906 (60/223) |
1.27E-13 |
Cyclin-dependent kinase 3 (CDK3)
|
|
27.861 (56/201) |
1.38E-13 |
Protein kinase C eta type (PRKCH)
|
|
27.602 (61/221) |
1.68E-13 |
Polo-like kinase 1 (PLK1)
|
|
28.241 (61/216) |
1.69E-13 |
Activin receptor type IB (ACVR1B)
|
|
24.667 (74/300) |
1.93E-13 |
Serine/threonine-protein kinase TAO2 (TAOK2)
|
|
27.477 (61/222) |
1.98E-13 |
TGF-beta receptor type I (TGFBR1)
|
|
24.157 (86/356) |
1.99E-13 |
Myosin light chain kinase 3 (MYLK3)
|
|
28.505 (61/214) |
2.01E-13 |
Tyrosine-protein kinase EIF2AK2 (p68)
|
|
22.870 (51/223) |
2.12E-13 |
Serine/threonine-protein kinase tousled-like 1 (TLK1)
|
|
26.754 (61/228) |
2.51E-13 |
Mitogen-activated protein kinase kinase kinase 15 (MAP3K15)
|
|
28.641 (59/206) |
2.52E-13 |
cAMP-dependent protein kinase catalytic subunit gamma (PRKACG)
|
|
24.506 (62/253) |
2.59E-13 |
cAMP-dependent protein kinase catalytic subunit PRKX (PRKX)
|
|
26.168 (56/214) |
2.67E-13 |
SPS1/STE20-related protein kinase YSK4 (YSK4)
|
|
24.419 (63/258) |
2.73E-13 |
Leucine-rich repeat kinase 2 (LRRK2)
|
|
23.970 (64/267) |
2.80E-13 |
Testis-specific serine/threonine-protein kinase 6 (TSSK6)
|
|
26.820 (70/261) |
2.82E-13 |
Cyclin-dependent kinase 1 (CDK1)
|
|
28.141 (56/199) |
3.19E-13 |
Testis-specific serine/threonine-protein kinase 3 (TSSK3)
|
|
26.641 (69/259) |
3.22E-13 |
Leucine-rich repeat serine/threonine-protein kinase 1 (LRRK1)
|
|
28.017 (65/232) |
3.28E-13 |
Testis-specific serine kinase 2 (TSSK2)
|
|
26.991 (61/226) |
3.47E-13 |
Death-associated protein kinase 2 (DAPK2)
|
|
27.650 (60/217) |
3.54E-13 |
Mitogen-activated protein kinase 13 (MAPK13)
|
|
29.557 (60/203) |
3.56E-13 |
Cyclin-dependent kinase 13 (CDK13)
|
|
24.336 (55/226) |
3.78E-13 |
Protein kinase C epsilon (PRKCE)
|
|
27.511 (63/229) |
3.81E-13 |
ERK activator kinase 7 (MAP2K7)
|
|
26.538 (69/260) |
4.01E-13 |
TAO kinase 1 (TAOK1)
|
|
29.439 (63/214) |
5.00E-13 |
BR serine/threonine kinase 1 (BRSK1)
|
|
25.287 (66/261) |
5.38E-13 |
Bone morphogenetic protein receptor (BMPR2)
|
|
27.350 (64/234) |
6.95E-13 |
Yet another novel kinase 2 (STK32B)
|
|
26.786 (60/224) |
7.01E-13 |
Serine/threonine-protein kinase Sgk1 (SGK1)
|
|
25.896 (65/251) |
7.23E-13 |
MEK kinase kinase 3 (MAP4K3)
|
|
26.263 (78/297) |
7.70E-13 |
Cyclin-dependent kinase-like 3 (CDKL3)
|
|
28.505 (61/214) |
9.06E-13 |
Protein kinase C theta (PRKCQ)
|
|
24.771 (54/218) |
9.17E-13 |
Doublecortin-like kinase 2 (DCLK2)
|
|
27.468 (64/233) |
1.12E-12 |
Serine/threonine-protein kinase NLK (NLK)
|
|
30.097 (62/206) |
1.34E-12 |
BR serine/threonine kinase 2 (BRSK2)
|
|
25.000 (59/236) |
1.38E-12 |
Dual specificity mitogen-activated protein kinase kinase 6 (MAP2K6)
|
|
26.820 (70/261) |
1.44E-12 |
Protein kinase C alpha (PRKCA)
|
|
26.296 (71/270) |
1.44E-12 |
Cyclin-dependent kinase 12 (CDK12)
|
|
24.762 (52/210) |
1.54E-12 |
Proto-oncogene serine/threonine-protein kinase mos (MOS)
|
|
26.333 (79/300) |
1.57E-12 |
Cyclin-dependent kinase 17 (CDK17)
|
|
25.373 (51/201) |
1.87E-12 |
Ribosomal protein S6 kinase beta-2 (RPS6KB2)
|
|
24.554 (55/224) |
1.93E-12 |
Cyclin-dependent kinase 14 (CDK14)
|
|
24.623 (49/199) |
2.24E-12 |
Cyclin-dependent kinase-like 2 (CDKL2)
|
|
31.343 (63/201) |
2.29E-12 |
MAPK/ERK kinase kinase 1 (MAP3K1)
|
|
22.535 (48/213) |
2.55E-12 |
Cyclin-dependent kinase 20 (CDK20)
|
|
27.907 (48/172) |
2.59E-12 |
IL-1 receptor-associated kinase 3 (IRAK3)
|
|
23.567 (74/314) |
2.63E-12 |
Doublecortin-like kinase 1 (DCLK1)
|
|
28.431 (58/204) |
2.67E-12 |
Calcium/calmodulin-dependent protein kinase type II subunit delta (CAMK2D)
|
|
25.110 (57/227) |
3.15E-12 |
Stress-activated protein kinase 2b (p38 beta)
|
|
26.360 (63/239) |
3.30E-12 |
Cyclin-dependent kinase 9 (CDK9)
|
|
26.829 (55/205) |
3.49E-12 |
Serine/threonine-protein kinase H2 (PSKH2)
|
|
26.971 (65/241) |
3.65E-12 |
Maternal embryonic leucine zipper kinase (MELK)
|
|
26.222 (59/225) |
3.80E-12 |
Cytoplasmic DRAK1 (STK17A)
|
|
26.106 (59/226) |
4.00E-12 |
Calcium/calmodulin-dependent protein kinase type II subunit beta (CAMK2B)
|
|
24.779 (56/226) |
4.00E-12 |
TRAF2 and NCK interacting kinase (TNIK)
|
|
25.091 (69/275) |
4.19E-12 |
Aurora kinase B (AURKB)
|
|
24.609 (63/256) |
4.71E-12 |
Cyclin-dependent kinase 16 (CDK16)
|
|
27.103 (58/214) |
5.18E-12 |
RAC-gamma serine/threonine-protein kinase (AKT3)
|
|
24.498 (61/249) |
5.25E-12 |
TAO kinase 3 (TAOK3)
|
|
28.774 (61/212) |
6.02E-12 |
SNF-related serine/threonine-protein kinase (SNRK)
|
|
22.761 (61/268) |
7.03E-12 |
Stress-activated protein kinase JNK3 (JNK3)
|
|
28.631 (69/241) |
8.03E-12 |
PAK-2 protein kinase (PAK2)
|
|
26.512 (57/215) |
8.55E-12 |
Serine/threonine-protein kinase Nek10 (NEK10)
|
|
25.431 (59/232) |
9.14E-12 |
MAPK/ERK kinase kinase 3 (MAP3K3)
|
|
24.906 (66/265) |
1.01E-11 |
IL-1 receptor-associated kinase 1 (IRAK1)
|
|
24.545 (81/330) |
1.10E-11 |
cAMP-dependent protein kinase catalytic subunit alpha (PRKACA)
|
|
24.111 (61/253) |
1.17E-11 |
MAPK/ERK kinase kinase 4 (MAP3K4)
|
|
27.948 (64/229) |
1.22E-11 |
Cyclin-dependent kinase 5 (CDK5)
|
|
24.889 (56/225) |
1.31E-11 |
Cyclin-dependent kinase 18 (CDK18)
|
|
25.701 (55/214) |
1.34E-11 |
Hormonally up-regulated neu tumor-associated kinase (HUNK)
|
|
23.755 (62/261) |
1.36E-11 |
Serine/threonine-protein kinase Sgk2 (SGK2)
|
|
26.104 (65/249) |
1.36E-11 |
RAC-beta serine/threonine-protein kinase (AKT2)
|
|
24.194 (60/248) |
1.38E-11 |
Dual specificity mitogen-activated protein kinase kinase 3 (MAP2K3)
|
|
27.969 (73/261) |
1.47E-11 |
Cyclin-dependent kinase 6 (CDK6)
|
|
26.180 (61/233) |
1.50E-11 |
Unc-51 like kinase 3 (ULK3)
|
|
23.967 (58/242) |
1.53E-11 |
Calcium/calmodulin-dependent protein kinase type II subunit gamma (CAMK2G)
|
|
23.451 (53/226) |
1.55E-11 |
Protein kinase G2 (PRKG2)
|
|
22.689 (108/476) |
1.78E-11 |
Stress-activated protein kinase 2a (p38 alpha)
|
|
24.257 (49/202) |
2.05E-11 |
PAK-1 protein kinase (PAK1)
|
|
26.168 (56/214) |
2.17E-11 |
Calcium/calmodulin-dependent protein kinase type IV (CAMK4)
|
|
27.072 (49/181) |
2.19E-11 |
Cyclin-dependent kinase 15 (CDK15)
|
|
23.153 (47/203) |
2.56E-11 |
Stress-activated protein kinase JNK2 (JNK2)
|
|
27.136 (54/199) |
2.70E-11 |
ERK activator kinase 1 (MEK1)
|
|
28.000 (56/200) |
2.73E-11 |
Protein kinase C beta (PRKCB)
|
|
26.147 (57/218) |
2.75E-11 |
Stress-activated protein kinase JNK1 (JNK1)
|
|
28.216 (68/241) |
3.26E-11 |
Cyclin-dependent kinase 11A (CDK11A)
|
|
27.861 (56/201) |
3.34E-11 |
Serine/threonine-protein kinase PAK 3 (PAK3)
|
|
26.636 (57/214) |
4.22E-11 |
Inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE)
|
|
25.943 (55/212) |
4.43E-11 |
Serine/threonine-protein kinase 32C (STK32C)
|
|
24.691 (60/243) |
4.47E-11 |
STE20-related kinase adapter protein alpha (STRADA)
|
|
25.652 (59/230) |
4.87E-11 |
Cyclin-dependent kinase-like 4 (CDKL4)
|
|
25.728 (53/206) |
5.54E-11 |
Cyclin-dependent kinase 11B (CDK11B)
|
|
27.500 (55/200) |
6.67E-11 |
G protein-coupled receptor kinase 6 (GRK6)
|
|
28.922 (59/204) |
7.65E-11 |
cAMP-dependent protein kinase catalytic subunit beta (PRKACB)
|
|
23.265 (57/245) |
8.75E-11 |
Doublecortin-like kinase 3 (DCLK3)
|
|
25.000 (49/196) |
1.02E-10 |
Serine/threonine-protein kinase WNK1 (WNK1)
|
|
27.239 (73/268) |
1.46E-10 |
Testis-specific serine/threonine-protein kinase 1 (TSSK1B)
|
|
25.551 (58/227) |
1.48E-10 |
STE20-related kinase adapter protein beta (STRADB)
|
|
26.316 (60/228) |
2.19E-10 |
ERK activator kinase 2 (MEK2)
|
|
26.263 (52/198) |
2.41E-10 |
Citron Rho-interacting kinase (CIT)
|
|
25.461 (69/271) |
2.45E-10 |
Serine/threonine-protein kinase 17B (STK17B)
|
|
26.106 (59/226) |
2.73E-10 |
MEK kinase kinase 1 (MAP4K1)
|
|
26.577 (59/222) |
3.22E-10 |
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (PHKG1)
|
|
25.131 (48/191) |
3.27E-10 |
MAPK/ERK kinase kinase 2 (MAP3K2)
|
|
25.000 (55/220) |
3.87E-10 |
Titin (TTN)
|
28.879 (67/232) |
4.37E-10 |
Protein kinase N1 (PKN1)
|
|
26.984 (68/252) |
4.37E-10 |
Misshapen-like kinase 1 (MINK1)
|
|
25.818 (71/275) |
4.50E-10 |
MAPK-activated protein kinase 3 (MAPKAPK3)
|
|
25.439 (58/228) |
5.52E-10 |
RAC-alpha serine/threonine-protein kinase (AKT1)
|
|
24.775 (55/222) |
7.53E-10 |
Myosin-IIIb (MYO3B)
|
|
27.803 (62/223) |
7.81E-10 |
NF-kappa-B-activating kinase (TBK1)
|
|
26.147 (57/218) |
8.33E-10 |
Cyclin-dependent kinase-like 5 (CDKL5)
|
|
25.258 (49/194) |
8.41E-10 |
Protein kinase C gamma (PRKCG)
|
|
26.207 (38/145) |
9.32E-10 |
Myosin-IIIa (MYO3A)
|
|
23.333 (63/270) |
9.95E-10 |
Cyclin-dependent kinase-like 1 (CDKL1)
|
|
26.633 (53/199) |
1.12E-09 |
MEK kinase kinase 4 (MAP4K4)
|
|
26.786 (60/224) |
1.34E-09 |
TGF-beta-stimulated factor 1 (STK16)
|
|
24.793 (60/242) |
1.38E-09 |
CaM-kinase IV kinase (CAMKK1)
|
|
29.885 (52/174) |
1.45E-09 |
WNK lysine-deficient protein kinase 3 (WNK3)
|
|
25.283 (67/265) |
1.62E-09 |
Cyclin-dependent kinase 10 (CDK10)
|
|
25.373 (51/201) |
1.80E-09 |
CDC42 binding protein kinase alpha (DMPK-like alpha)
|
|
25.316 (60/237) |
2.12E-09 |
Cyclin-dependent kinase 4 (CDK4)
|
|
26.442 (55/208) |
2.65E-09 |
Ribosomal protein S6 kinase-related protein (RSKR)
|
|
28.079 (57/203) |
2.68E-09 |
MEK kinase kinase 2 (MAP4K2)
|
|
26.804 (52/194) |
2.72E-09 |
Protein kinase C iota (PRKCI)
|
|
26.961 (55/204) |
2.96E-09 |
Protein kinase N3 (PKN3)
|
|
24.696 (61/247) |
3.16E-09 |
Mitogen-activated protein kinase 6 (MAPK6)
|
|
28.141 (56/199) |
3.45E-09 |
G protein-coupled receptor kinase 5 (GRK5)
|
|
26.341 (54/205) |
3.73E-09 |
G protein-coupled receptor kinase 4 (GRK4)
|
|
26.457 (59/223) |
5.28E-09 |
Dual specificity mitogen-activated protein kinase kinase 4 (MAP2K4)
|
|
25.461 (69/271) |
5.92E-09 |
MAPK-activated protein kinase 2 (MAPKAPK2)
|
|
25.806 (40/155) |
6.55E-09 |
Protein kinase N2 (PKN2)
|
|
27.650 (60/217) |
6.58E-09 |
Beta-adrenergic receptor kinase 2 (ADRBK2)
|
|
24.766 (53/214) |
7.27E-09 |
Glycogen synthase kinase-3 alpha (GSK-3A)
|
|
25.763 (76/295) |
9.58E-09 |
Activin receptor type IIA (ACVR2A)
|
|
25.000 (53/212) |
1.05E-08 |
Serine/threonine-protein kinase pim-1 (PIM1)
|
|
24.735 (70/283) |
1.13E-08 |
Rhodopsin kinase GRK7 (GRK7)
|
|
25.714 (54/210) |
1.34E-08 |
Calmodulin-dependent kinase II (CAMKK2)
|
|
27.381 (46/168) |
1.42E-08 |
Phosphorylase kinase testis gamma 2 (PHKG2)
|
|
23.529 (44/187) |
1.81E-08 |
Protein kinase C zeta (PRKCZ)
|
|
24.051 (57/237) |
1.86E-08 |
Rho-associated protein kinase 2 (ROCK2)
|
|
27.103 (58/214) |
1.95E-08 |
Beta-adrenergic receptor kinase 1 (ADRBK1)
|
|
24.766 (53/214) |
2.60E-08 |
MAPK/MAK/MRK overlapping kinase (MOK)
|
|
26.872 (61/227) |
2.69E-08 |
Protein kinase G1 (PRKG1)
|
|
25.234 (54/214) |
2.94E-08 |
Ribosomal protein S6 kinase alpha-4 (RPS6KA4)
|
|
28.025 (44/157) |
3.14E-08 |
Serine/threonine-protein kinase Chk2 (RAD53)
|
|
24.569 (57/232) |
4.29E-08 |
Anti-mullerian hormone II receptor (AMHR2)
|
|
23.035 (85/369) |
4.73E-08 |
Serine/threonine-protein kinase MRCK beta (CDC42BPB)
|
|
25.498 (64/251) |
4.97E-08 |
Nik-related protein kinase (NRK)
|
|
23.875 (69/289) |
5.12E-08 |
Mitogen-activated protein kinase 4 (MAPK4)
|
|
24.044 (44/183) |
5.41E-08 |
PDZ binding kinase (PBK)
|
|
21.622 (40/185) |
6.77E-08 |
Mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5)
|
|
25.121 (52/207) |
8.44E-08 |
Serine/threonine-protein kinase greatwall (MASTL)
|
|
27.027 (40/148) |
8.70E-08 |
Cyclin-dependent kinase 19 (CDK19)
|
|
25.000 (52/208) |
9.84E-08 |
Peripheral plasma membrane protein CASK (CASK)
|
|
25.000 (53/212) |
1.05E-07 |
Triple functional domain protein (TRIO)
|
|
26.570 (55/207) |
1.05E-07 |
Serine/threonine-protein kinase pim-2 (PIM2)
|
|
26.752 (42/157) |
1.07E-07 |
Serine/threonine-protein kinase NIK (MAP3K14)
|
|
24.815 (67/270) |
1.11E-07 |
Tau-tubulin kinase 2 (TTBK2)
|
|
22.672 (56/247) |
1.15E-07 |
Microtubule-associated serine/threonine-protein kinase 2 (MAST2)
|
|
25.604 (53/207) |
1.21E-07 |
Microtubule-associated serine/threonine-protein kinase 4 (MAST4)
|
|
27.064 (59/218) |
1.23E-07 |
Rho-associated protein kinase 1 (ROCK1)
|
|
24.242 (64/264) |
1.32E-07 |
Testis-specific serine/threonine-protein kinase 4 (TSSK4)
|
|
20.000 (50/250) |
1.39E-07 |
Serine/threonine-protein kinase STK11 (STK11)
|
|
23.445 (49/209) |
1.39E-07 |
NDR1 protein kinase (STK38)
|
|
23.569 (70/297) |
1.50E-07 |
Serine/threonine-protein kinase WNK2 (WNK2)
|
|
27.155 (63/232) |
1.56E-07 |
Membrane-associated kinase (PKMYT1)
|
|
26.754 (61/228) |
2.06E-07 |
NDR2 protein kinase (STK38L)
|
|
24.031 (62/258) |
2.15E-07 |
MAPK-activated protein kinase 5 (MAPKAPK5)
|
|
25.668 (48/187) |
2.17E-07 |
Serine/threonine-protein kinase MRCK gamma (CDC42BPG)
|
|
25.094 (67/267) |
2.30E-07 |
PIM-3 protein kinase (PIM3)
|
|
26.829 (55/205) |
2.45E-07 |
PRKR-like endoplasmic reticulum kinase (PERK)
|
|
28.571 (28/98) |
2.98E-07 |
Glycogen synthase kinase-3 beta (GSK-3B)
|
|
26.341 (54/205) |
3.06E-07 |
Striated muscle preferentially expressed protein kinase (SPEG)
|
|
22.857 (48/210) |
4.78E-07 |
Endoplasmic reticulum to nucleus signaling 1 (ERN1)
|
|
25.397 (48/189) |
6.29E-07 |
Microtubule-associated serine/threonine-protein kinase 3 (MAST3)
|
|
26.627 (45/169) |
7.25E-07 |
CaM kinase-like vesicle-associated protein (CAMKV)
|
|
23.013 (55/239) |
7.84E-07 |
Serine/threonine-protein kinase cot (COT)
|
|
23.923 (50/209) |
8.62E-07 |
Microtubule-associated serine/threonine-protein kinase 1 (MAST1)
|
|
28.889 (39/135) |
9.64E-07 |
Eukaryotic translation initiation factor 2-alpha kinase 1 (EIF2AK1)
|
|
26.812 (37/138) |
9.66E-07 |
Serine/threonine kinase-like domain-containing protein STKLD1 (STKLD1)
|
|
28.866 (28/97) |
9.67E-07 |
Interleukin-1 receptor-associated kinase-like 2 (IRAK2)
|
|
24.876 (50/201) |
1.08E-06 |
Homeodomain-interacting protein kinase 4 (HIPK4)
|
|
24.895 (59/237) |
1.32E-06 |
Serine/threonine-protein kinase Kist (UHMK1)
|
|
30.380 (48/158) |
1.37E-06 |
Cyclin-G-associated kinase (GAK)
|
|
22.393 (73/326) |
2.09E-06 |
Serine/threonine-protein kinase PDIK1L (PDIK1L)
|
|
22.709 (57/251) |
2.14E-06 |
Homeodomain interacting protein kinase 2 (HIPK2)
|
|
27.897 (65/233) |
2.20E-06 |
Cyclin-dependent kinase 8 (CDK8)
|
|
25.000 (41/164) |
2.22E-06 |
Homeodomain-interacting protein kinase 3 (HIPK3)
|
|
26.840 (62/231) |
2.73E-06 |
Serine/threonine-protein kinase LATS1 (LATS1)
|
|
26.543 (43/162) |
2.98E-06 |
PAS domain-containing serine/threonine-protein kinase (PASK)
|
|
23.077 (51/221) |
3.23E-06 |
Homeodomain-interacting protein kinase 1 (HIPK1)
|
|
27.897 (65/233) |
3.48E-06 |
Serine/threonine-protein kinase ULK4 (ULK4)
|
|
21.739 (40/184) |
3.86E-06 |
Serine/threonine-protein kinase/endoribonuclease IRE2 (ERN2)
|
|
28.191 (53/188) |
4.53E-06 |
Activin receptor type IIB (ACVR2B)
|
|
22.273 (49/220) |
4.89E-06 |
Large tumor suppressor homolog 2 (LATS2)
|
|
21.887 (58/265) |
6.50E-06 |
Rhodopsin kinase GRK1 (GRK1)
|
|
23.000 (46/200) |
7.77E-06 |
Eukaryotic translation initiation factor 2-alpha kinase 4 (EIF2AK4)
|
|
28.481 (45/158) |
7.98E-06 |
Tau-tubulin kinase (TTBK1)
|
|
22.609 (52/230) |
1.51E-05 |
Laminin subunit alpha-5 (LAMA5)
|
|
31.915 (30/94) |
2.56E-05 |
TBC domain-containing protein kinase-like protein (TBCK)
|
|
22.835 (58/254) |
4.26E-05 |
Dual-specificity tyrosine-phosphorylation regulated kinase 3 (DYRK3)
|
|
23.735 (61/257) |
7.22E-05 |
Myotonin-protein kinase (DMPK)
|
|
23.348 (53/227) |
9.43E-05 |
Serine/threonine-protein kinase SBK2 (SBK2)
|
|
24.378 (49/201) |
1.46E-04 |
MAP kinase signal-integrating kinase 2 (MKNK2)
|
|
22.967 (48/209) |
2.57E-04 |
Dual specificity protein kinase TTK (MPS1)
|
|
26.027 (38/146) |
2.98E-04 |
Dual-specificity tyrosine-phosphorylation regulated kinase 1B (DYRK1B)
|
|
25.185 (68/270) |
6.66E-04 |
Sugen kinase 110 (SBK3)
|
|
26.282 (41/156) |
1.00E-03 |
Serine/threonine-protein kinase 40 (STK40)
|
|
24.031 (31/129) |
1.00E-03 |
Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 (ARAP3)
|
|
30.357 (17/56) |
2.00E-03 |
SCY1-like protein 2 (SCYL2)
|
|
25.203 (31/123) |
3.00E-03 |
Serine/threonine-protein kinase 35 (STK35)
|
|
26.241 (37/141) |
3.00E-03 |
CDC7-related kinase (CDC7)
|
|
23.013 (55/239) |
4.00E-03 |
Click to Show/Hide the Information of Human Similarity Proteins |